91 related articles for article (PubMed ID: 21495929)
1. Salvage therapy for relapsed chronic lymphocytic leukemia.
Andritsos LA; Grever MR
Expert Rev Hematol; 2011 Apr; 4(2):199-212. PubMed ID: 21495929
[TBL] [Abstract][Full Text] [Related]
2. [Conventional therapeutic strategies for relapsed chronic lymphocytic leukemia].
Guièze R; Ysebaert L; de Guibert S; Dhédin N; Bay JO; Troussard X; Tournilhac O
Bull Cancer; 2012 Dec; 99(12):1123-32. PubMed ID: 23249977
[TBL] [Abstract][Full Text] [Related]
3. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
[TBL] [Abstract][Full Text] [Related]
4. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
7. [Chronic lymphocytic leukemia].
Wendtner CM
Dtsch Med Wochenschr; 2012 Jun; 137(22):1162-5. PubMed ID: 22619012
[No Abstract] [Full Text] [Related]
8. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in chronic lymphocytic leukemia.
Abbott BL
Cancer Invest; 2006; 24(3):302-9. PubMed ID: 16809159
[TBL] [Abstract][Full Text] [Related]
10. Current strategies for treatment of relapsed/refractory multiple myeloma.
Laubach JP; Voorhees PM; Hassoun H; Jakubowiak A; Lonial S; Richardson PG
Expert Rev Hematol; 2014 Feb; 7(1):97-111. PubMed ID: 24471924
[TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
Goodrich A
Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):23-36. PubMed ID: 17474175
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia: recent advances in diagnosis and treatment.
Abbott BL
Oncologist; 2006 Jan; 11(1):21-30. PubMed ID: 16401710
[TBL] [Abstract][Full Text] [Related]
14. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.
Banerji V; Johnston JB; Seftel MD
Transfus Apher Sci; 2007 Aug; 37(1):57-62. PubMed ID: 17919979
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF
Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
[TBL] [Abstract][Full Text] [Related]
17. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia.
Santos ES; Masri M; Safah H
Expert Rev Anticancer Ther; 2005 Oct; 5(5):875-91. PubMed ID: 16221057
[TBL] [Abstract][Full Text] [Related]
20. High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation.
Bug G; Atta J; Klein SA; Hertenstein B; Bergmann L; Boehrer S; Mousset S; Hoelzer D; Martin H
Ann Hematol; 2005 Oct; 84(11):748-54. PubMed ID: 16001243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]